Bin gespannt...
|
Phase 1/2A GEN-009
ir.genocea.com/news-releases/...-009-neoantigen-vaccine-phase
Zahlen für Q3/20
Genocea expects that its existing cash and cash equivalents are sufficient to support its operations to mid-2022.
ir.genocea.com/news-releases/...quarter-2020-corporate-update
Zahlen für Q2/21
Genocea’s operating plan extends its cash runway to the end of 2022
ir.genocea.com/news-releases/...quarter-2021-corporate-update
Zahlen für Q3/21
ir.genocea.com/news-releases/...quarter-2021-corporate-update
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 36 | Resplit bei Genocea Biosciences | moneywork4me | Vassago | 08.03.22 07:09 |